Osteoporosis Disease Management Demonstration Project (0000-040)

Osteoporosis Clinical Trial

Official title:

Three Methods of Delivering Health Care for Secondary Prevention of Osteoporosis

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00145067
• Other study ID #: 0000-040
• Secondary ID: 0402005_051
• Status: Completed
• Phase: N/A
• First received: September 1, 2005
• Last updated: November 2, 2015
• Start date: November 2003
• Est. completion date: June 2006

Study information

• Verified date: November 2015
• Source: Merck Sharp & Dohme Corp.
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to evaluate the impact disease management interventions in treatment compliance among post-fracture and osteoporosis patients.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 230
• Est. completion date: June 2006
• Est. primary completion date: June 2006
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 60 Years and older

Eligibility

Inclusion Criteria:

• Members of of the Kaiser Permanente Health Plan who have fractured a bone.

Exclusion Criteria:

• Individuals who are not members of the Kaiser Permanente Health Plan.

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Osteoporosis

Intervention

Behavioral:
• Disease Management Assessment

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Merck Sharp & Dohme Corp.

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Treatment persistence
Secondary	Patient satisfaction and knowledge